ChemoCentryx, Inc. (CCXI) Social Stream
CHEMOCENTRYX INC (CCXI) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CCXI.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $107 | $38 | $74.5 | $51.98 | 43.32% |
| 2022-03-02 | 6 | $110 | $40 | $75.333 | $51.98 | 44.93% |
| 2022-05-05 | 6 | $110 | $30 | $73.666 | $51.98 | 41.72% |
| 2022-05-06 | 6 | $106 | $30 | $73.166 | $51.98 | 40.76% |
| 2022-07-25 | 6 | $106 | $34 | $73.833 | $51.98 | 42.04% |
| 2022-08-04 | 7 | $106 | $34 | $74.857 | $51.98 | 44.01% |
| 2022-08-05 | 7 | $106 | $34 | $63.714 | $51.98 | 22.57% |
| 2022-08-09 | 7 | $86 | $52 | $57.666 | $51.98 | 10.94% |
| 2022-08-10 | 7 | $52 | $52 | $52 | $51.98 | 0.04% |
The Trend in the Analyst Price Target
CCXI's average price target has moved down $21.86 over the prior 27 months.
CCXI reports an average of 171.86% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-18 | 6 | 110 | 40 | 75.333 | 30.70 | 145.38% |
| 2022-03-02 | 6 | 110 | 40 | 75.333 | 24.55 | 206.86% |
| 2022-05-06 | 6 | 106 | 30 | 73.166 | 17.38 | 320.98% |
| 2022-05-11 | 6 | 106 | 34 | 73.833 | 16.49 | 347.74% |
| 2022-08-04 | 7 | 106 | 34 | 74.857 | 50.43 | 48.44% |
CCXI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 7 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 92 days, CCXI's average broker recommendation rating worsened by 1.67.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CHEMOCENTRYX INC's variance in analysts' estimates is lower than -766.24% of them.
- CCXI has a greater upside potential (average analyst target price relative to current price) than 176.15% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, CHEMOCENTRYX INC's average analyst price target is greater than 868.44% of them.
- In terms of how CHEMOCENTRYX INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 462.93% of that group.
Stocks similar to CHEMOCENTRYX INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BPMC, BBIO, and AXSM.
View All Top Stocks by Price Target
Make investment decisions regarding CCXI using the data that counts. Try POWR Ratings for free.